Sonographic Evaluation Of Uterine Fibroids At Different Locations In Patient With Irregular Menstrul Cycle

Uterine fibroids are a major cause of illness in women of a reproductive age. There are many factors involved in the growth and reduction of these common tumors. The most likely cause of fibroids is their effect on a woman's menstrual cycle. For accurate diagnosis numerous diagnostic markers on ultrasound are present which increases the efficacy of ultrasound to diagnose uterine fibroids.

Active, Not Recruiting

This study is active but is not currently recruiting participants.

Notify Me

Key information

Conditions

Menstrual Irregularity Menstruation Disturbances Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

15 year–35 year

Sex eligibility

Female

Study type

Observational

Primary location

THQ hospital Pattoki/ Siddique medical center Pattoki

Pattoki, Punjab Province, Pakistan

About this study

To evaluate the different location of uterine fibroids in patient with disturbed menstrual cycle on Ultrasound.

The descriptive and cross-sectional study was conducted. A total of 97 patient data were collected. All the patients with uterine fibroids due to heavy bleeding, abdominal pain, pelvic pain, disturbance in menstrual cycle undergoing ultrasound were included.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patient with Pelvic pain
Patient with Abdominal pain
Patient with heavy bleeding
Patient with Dysmenorrhea
Polymenorrhea

Exclusion criteria

Patient with H/O Cystectomy
Patient with H/O cyst

Treatment and study plan

Ultrasound

Radiation

To evaluate the different location of uterine fibroids in patient with disturbed menstrual cycle on ultrasound

Primary outcomes

two-dimensional ultrasound scan (GE Loginq P7 convex probe.3.5-5MHz)

Time frame: 12 Months

On ultrasound using (GE Loginq P7 convex probe.3.5-5MHz), a uterine fibroid is classically characterized as a solid, round, well-defined, hypoechoic, heterogeneous lesion within the myometrium, often showing acoustic shadowing at the edge of the lesion

Sponsors and collaborators

Lead sponsor

Superior University

Other

Registry information

Important dates

Study start: 2024
Primary completion: 2024
Study completion: 2025
First posted: Jan 10, 2025
Registry last updated: Jan 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting